Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.

Most vaccines contain an infectious pathogen or a part of it, but mRNA vaccines deliver the genetic instructions for our cells to make viral or bacterial proteins themselves. Our immune system ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...

Messenger RNA, or mRNA, vaccines work by instructing a small number of a person’s cells to make specific proteins. In the case of the approved mRNA vaccines for COVID-19, the cells make spike protein ...

A new study suggests that these vaccines might boost the effects of immunotherapy drugs, perhaps by alerting the immune ...

In the fast-evolving field of medical science, a new artificial intelligence model may be about to change the way mRNA-based drugs and vaccines are designed. Developed through a collaboration between ...

Katalin Karikó and Dr. Drew Weissman, American scientists whose long collaboration has revolutionized the making of vaccines and raised the prospect of new treatments for a range of afflictions, were ...

Researchers at Karolinska Institutet have discovered how cells can adjust their gene activity to survive when oxygen runs low ...